Provided by Tiger Trade Technology Pte. Ltd.

Corcept Therapeutics

111.80
-0.9900-0.88%
Post-market: 111.800.00000.00%16:27 EDT
Volume:1.18M
Turnover:132.69M
Market Cap:12.09B
PE:246.44
High:114.52
Open:113.38
Low:111.10
Close:112.79
52wk High:126.38
52wk Low:28.66
Shares:108.10M
Float Shares:96.44M
Volume Ratio:1.41
T/O Rate:1.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4537
EPS(LYR):0.8200
ROE:8.23%
ROA:0.47%
PB:17.12
PE(LYR):136.34

Loading ...

Aug 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 02, 2023

Major Issues Report

Form 8-K - Current report
Aug 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 25, 2023

Major Issues Report

Form 8-K - Current report
May 09, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 03, 2023

Major Issues Report

8-K - Current report
May 03, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Major Issues Report

8-K - Current report
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 08, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 22, 2022

Major Issues Report

8-K - Current report